140 related articles for article (PubMed ID: 21139707)
1. Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales' disease): implication for anti-TNF-α therapy.
Saxena S; Pant AB; Khanna VK; Singh K; Shukla RK; Meyer CH; Singh VK
J Ocul Biol Dis Infor; 2010 Jul; 3(1):35-8. PubMed ID: 21139707
[TBL] [Abstract][Full Text] [Related]
2. A Review of Eales' Disease and
Bae K; Alcantara CA; Kim J; Tsui C; Venketaraman V
Biology (Basel); 2024 Jun; 13(6):. PubMed ID: 38927340
[TBL] [Abstract][Full Text] [Related]
3. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease.
Saxena S; Khanna VK; Pant AB; Meyer CH; Singh VK
Pathobiology; 2011; 78(5):261-5. PubMed ID: 21849807
[TBL] [Abstract][Full Text] [Related]
4. The clinical picture of Eales' disease.
Spitznas M; Meyer-Schwickerath G; Stephan B
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975; 194(2):73-85. PubMed ID: 1080369
[TBL] [Abstract][Full Text] [Related]
5. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease.
Saxena S; Srivastava P; Kumar D; Khanna VK; Seth PK
Ocul Immunol Inflamm; 2006 Apr; 14(2):113-6. PubMed ID: 16597541
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease.
Saxena S; Pant AB; Khanna VK; Agarwal AK; Singh K; Kumar D; Singh VK
Ocul Immunol Inflamm; 2009; 17(3):201-6. PubMed ID: 19585364
[TBL] [Abstract][Full Text] [Related]
7. Eales' disease: the great masquerader.
Davis J; Schecter SH; Sowka J
Optometry; 2009 Jul; 80(7):354-9. PubMed ID: 19545848
[TBL] [Abstract][Full Text] [Related]
8. [Eales' disease].
Errera MH; Pratas A; Goldschmidt P; Sedira N; Sahel JA; Benesty J
J Fr Ophtalmol; 2016 May; 39(5):474-82. PubMed ID: 27185661
[TBL] [Abstract][Full Text] [Related]
9. Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales' disease.
Sen A; Paine SK; Chowdhury IH; Mondal LK; Mukherjee A; Biswas A; Chowdhury S; Bhattacharya S; Bhattacharya B
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):171-8. PubMed ID: 20720222
[TBL] [Abstract][Full Text] [Related]
10. New classification system-based visual outcome in Eales' disease.
Saxena S; Kumar D
Indian J Ophthalmol; 2007; 55(4):267-9. PubMed ID: 17595474
[TBL] [Abstract][Full Text] [Related]
11. Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage.
Bhooma V; Sulochana KN; Biswas J; Ramakrishnan S
Curr Eye Res; 1997 Feb; 16(2):91-5. PubMed ID: 9068938
[TBL] [Abstract][Full Text] [Related]
12. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
[TBL] [Abstract][Full Text] [Related]
13. A new staging system for idiopathic retinal periphlebitis.
Saxena S; Kumar D
Eur J Ophthalmol; 2004; 14(3):236-9. PubMed ID: 15206649
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant supplementation improves platelet membrane fluidity in idiopathic retinal periphlebitis (Eales' disease).
Saxena S; Srivastava P; Khanna VK
J Ocul Pharmacol Ther; 2010 Dec; 26(6):623-6. PubMed ID: 20973744
[TBL] [Abstract][Full Text] [Related]
15. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).
El-Asrar AM; Al-Kharashi SA
Br J Ophthalmol; 2002 Nov; 86(11):1248-51. PubMed ID: 12386081
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
[TBL] [Abstract][Full Text] [Related]
17. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
[TBL] [Abstract][Full Text] [Related]
18. [Role of the argon laser in the treatment of Eales' disease, idiopathic periphlebitis and hemoglobinopathies].
Van Effenterre G; Haut J; Demoule B; Guiberteau B; Cahiza M
Bull Soc Ophtalmol Fr; 1979; 79(4-5):457-61. PubMed ID: 575078
[No Abstract] [Full Text] [Related]
19. Association of mycobacteria with Eales' disease.
Therese KL; Deepa P; Therese J; Bagyalakshmi R; Biswas J; Madhavan HN
Indian J Med Res; 2007 Jul; 126(1):56-62. PubMed ID: 17890825
[TBL] [Abstract][Full Text] [Related]
20. [Unusual aspect of retinal periphlebitis in Eales' disease].
FEUVRIER YM; CATROS A; LOREAL ; ARDOUIN M
Bull Soc Ophtalmol Fr; 1959 Jan; 1():107-15. PubMed ID: 13651889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
